Bruker Corporation  

(Public, NASDAQ:BRKR)   Watch this stock  
Find more results for BRKR
+0.11 (0.49%)
Dec 2 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 22.42 - 22.81
52 week 19.58 - 29.85
Open 22.42
Vol / Avg. 587,963.00/674,939.00
Mkt cap 3.65B
P/E 25.53
Div/yield 0.04/0.71
EPS 0.89
Shares 160.40M
Beta 1.04
Inst. own 69%
Feb 8, 2017
Q4 2016 Bruker Corp Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Nov 2, 2016
Q3 2016 Bruker Corp Earnings Call
Nov 2, 2016
Q3 2016 Bruker Corp Earnings Release
Sep 12, 2016
Bruker Corp at Morgan Stanley Global Healthcare Conference
Sep 7, 2016
Bruker Corp at Wells Fargo Securities Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin 11.93% 6.46%
Operating margin 11.65% 8.97%
EBITD margin - 13.14%
Return on average assets 10.72% 5.84%
Return on average equity 27.48% 13.62%
Employees 6,000 -
CDP Score - -


United States - Map
+1-978-6633660 (Phone)
+1-978-6635585 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company's operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive (CBRNE) detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices.

Officers and directors

Frank H. Laukien Ph.D. Chairman of the Board, President, Chief Executive Officer
Age: 56
Bio & Compensation  - Reuters
Anthony L. Mattacchione Chief Financial Officer, Senior Vice President
Age: 52
Bio & Compensation  - Reuters
Rene Lenggenhager President - Bruker BioSpin Group
Age: 56
Bio & Compensation  - Reuters
Juergen Srega President of Bruker CALID Group and Bruker Daltonics Division
Age: 61
Bio & Compensation  - Reuters
Mark Robert Munch Ph.D. Executive Vice President ; President - Bruker Nano Surfaces Division and Bruker MAT Group
Age: 54
Bio & Compensation  - Reuters
Michael Gunnar Knell Vice President - Finance, Chief Accounting Officer
Age: 39
Bio & Compensation  - Reuters
William A. Linton Lead Independent Director
Age: 68
Bio & Compensation  - Reuters
Joerg C. Laukien Director
Age: 62
Bio & Compensation  - Reuters
Stephen W. Fesik Ph.D. Independent Director
Age: 62
Bio & Compensation  - Reuters
Marc A. Kastner Ph.D. Independent Director
Age: 70
Bio & Compensation  - Reuters